# The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer

> **NCT06483919** · — · ACTIVE_NOT_RECRUITING · sponsor: **Jinming Yu** · enrollment: 228 (estimated)

## Conditions studied

- Small-cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06483919
- **Lead sponsor:** Jinming Yu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-10-01
- **Primary completion:** 2025-01-30
- **Final completion:** 2025-01-30
- **Target enrollment:** 228 (ESTIMATED)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06483919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06483919, "The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06483919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*